Data as of Jun 17
| +0.02 / +0.26%|
The 2 analysts offering 12-month price forecasts for MEI Pharma Inc have a median target of 13.50, with a high estimate of 16.00 and a low estimate of 11.00. The median estimate represents a +77.17% increase from the last price of 7.62.
The current consensus among 3 polled investment analysts is to Buy stock in MEI Pharma Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.